Institutional members access full text with Ovid®

Share this article on:

Role of lipids in the control of food intake

Fantino, Marc

Current Opinion in Clinical Nutrition & Metabolic Care: March 2011 - Volume 14 - Issue 2 - p 138–144
doi: 10.1097/MCO.0b013e3283437b78
Lipid metabolism and therapy: Edited by Philip C. Calder and Richard J. Deckelbaum

Purpose of review The classical hypothesis that a decrease in glucose utilization, registered by specific sensors in the brain, leads to hunger was challenged as lipids and amino acids also provide energy for cell metabolism. This review presents recent progress in the knowledge on lipid signals associated with feeding initiation or inhibition.

Recent findings Although the brain does not utilize fatty acids as primary energy sources, recent evidence indicates that intermediates of fatty acids metabolism in the hypothalamus serve as sensors of energy status. Pharmacological or genetic inhibition of brain fatty-acid synthase and carnitine palmitoyltransferase-1c results in profound decreases in feeding and body weight in rodents. These effects depend on changes in the intracytoplasmic pool of long-chain fatty-acyl-CoA and malonyl-CoA, an intermediate of the de-novo fatty acid synthesis in neurons that integrate hormonal and nutrient-derived signals to control feeding behaviour. The central regulatory enzyme is AMP-activated protein kinase, which reversibly phosphorylates acetyl-CoA carboxylase and malonyl-CoA decarboxylase, two enzymes that increase the level of malonyl-CoA in the cells when phosphorylated in response to a low intracellular ratio of AMP/ATP due to decrease in glucose oxidation.

Summary Such a mechanism is compatible with a central energostatic control of feeding based on glucose utilization by neurons and opens new therapeutic perspectives to develop pharmacological compounds that act at the level of pivotal enzymes such as AMP-activated protein kinase, acetyl-CoA carboxylase, malonyl-CoA decarboxylase, and module malonyl-CoA level in cells, to favour central inhibition of feeding.

Medical School Hospital of the Burgundy University, Dijon, France

Correspondence to Pr Marc Fantino, CREABio, Faculté de Médecine, 7, Boulevard Jeanne d'Arc, BP 87900, F-21079 Dijon cedex, France Tel: +33 3 80 29 34 47; fax: +33 3 80 29 36 59; e-mail:

© 2011 Lippincott Williams & Wilkins, Inc.